Latest News

© BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Creating a Framework for Increased Accessibility in Palliative Care Research

March 1st 2024

With inequalities in palliative care provisions, recent study seeks to create a more equitable, diverse, and inclusive framework based on Patient and Public Involvement.

Image credit: Dr_Microbe | stock.adobe.com. Hairy cell leukemia, 3D illustration. It is a hematological malignancy, chronic lymphocytic leukemia, with accumulation of abnormal B lymphocytes
Matching Adjusted Indirect Comparison of Trial Data Indicate Survival Advantage with Brukinsa Over Calquence for CLL

March 1st 2024

Chris Moore, president, Veeva Europe
Accelerating Time to Treatment in Rare Disease

March 1st 2024

Image credit: DC Studio | stock.adobe.com
Generational Differences Among African Americans, Their Experiences with the Healthcare System

February 29th 2024

© Jakub Krechowicz - © Jakub Krechowicz - stock.adobe.com
The Current State of Diversity in Randomized Clinical Trials for Peripheral Artery Disease

February 29th 2024

Conference Coverage

View All
SCOPE 2024: YPrime CEO, Jim Corrigan Speaks About the Company and Addressing Uncertainty in Clinical Trials
SCOPE 2024: YPrime CEO, Jim Corrigan Speaks About the Company and Addressing Uncertainty in Clinical Trials

February 19th 2024

SCOPE 2024: Alex Deyle of Flatiron Health Discusses RWD in Clinical Trials
SCOPE 2024: Alex Deyle of Flatiron Health Discusses RWD in Clinical Trials

February 14th 2024

SCOPE 2024: Steve Young of CluePoints Discusses RBQM and Key Risk Indicators
SCOPE 2024: Steve Young of CluePoints Discusses RBQM and Key Risk Indicators

February 13th 2024

SCOPE 2024: Todd Everhart of Signant Health Discusses DCTs and Site Burden
SCOPE 2024: Todd Everhart of Signant Health Discusses DCTs and Site Burden

February 13th 2024

Latest Videos
Podcasts
© Alex from the Rock - © Alex from the Rock - stock.adobe.com
Rinol Alaj, Jaclyn Patterson, Applied Clincial Trials Podcast

All News

© 2024 MJH Life Sciences

All rights reserved.